Catalytic oxidation of emissions in combustion systems for forest biomass, using catalysts with TiO2 support

A study was made of the catalytic oxidation of a model mixture of effluents from forest biomass combustion equipment, consisting principally of methane (CH4), naphthalene (C10H8), carbon monoxide (CO) and oxygen-poor air (10% O2, balance N2), in a laboratory reactor, using MeOx/TiO2 catalysts (Me = Fe, Cu or Mn), prepared using incipient wetness impregnation. It was observed that the addition of metal oxides to the TiO2 increases catalytic activity in the combustion of all the contaminants present in the model effluent (CH 4, C10H8 and CO). The catalysts were characterised using the following techniques: SBET, XRD, DTG/DTA and TPD-NH 3; and from these it was observed that the support presented only the anatase phase in all the catalysts, despite having been subjected to temperatures in excess of 1.000 K during combustion. The highest acidity among all the solids tested, measured by TPD-NH3, was obtained for the FeOx/TiO2 catalysts, which were also those which showed the greatest catalytic activity. This high level of activity may be related to the formation of isolated metallic phases; i.e. hematite (Fe2O3), which would be the active phase in the combustion of C10H8 and CH4. On the other hand, with to respect to the 5 % wt. values of Me/TiO2 (Me: Fe, Cu y Mn) catalysts, the CuO/TiO2 catalyst shows greater activity than Fe2O3/TiO2 and MnOx/TiO2 for the oxidation of CO, which would be related to the formation of CuO on the TiO2 surface. The formation of mixed phases between the metals and the TiO2 was not observed. The SBET of the most active catalyst, Fe2O3/TiO2 (where Fe is 5% w/w in value), was not subject to any changes during the reaction

Una visión del problema de las malezas en colombia

Este trabajo, son notas a cerca del problema que significa la vegetación adventicia en los sistemas de cultivos de un país tropical como Colombia. Se consideran entre otros aspectos, la actitud de los diversos estamentos involucrados en la producción aqrícola frente al problema de las malezas, la estimación de pérdidas en los cultivos debidas a las malezas, se mencionan algunas de las especies de arvenses de importancia económica de acuerdo con la altitud, los métodos y tecnologías utilizadas para manejar estas especies y finalmente, se hacen algunasconsideraciones acerca del estado actual en Colombia sobre la investigación, decencia y extensión en Malherbología

Validation of Electroencephalographic Recordings Obtained with a Consumer-Grade, Single Dry Electrode, Low-Cost Device: A Comparative Study

The functional validity of the signal obtained with low-cost electroencephalography (EEG) devices is still under debate. Here, we have conducted an in-depth comparison of the EEG-recordings obtained with a medical-grade golden-cup electrodes ambulatory device, the SOMNOwatch + EEG-6, vs those obtained with a consumer-grade, single dry electrode low-cost device, the NeuroSky MindWave, one of the most a ordable devices currently available. We recorded EEG signals at Fp1 using the two di erent devices simultaneously on 21 participants who underwent two experimental phases: a 12-minute resting state task (alternating two cycles of closed/open eyes periods), followed by 60-minute virtual-driving task. We evaluated the EEG recording quality by comparing the similarity between the temporal data series, their spectra, their signal-to-noise ratio, the reliability of EEG measurements (comparing the closed eyes periods), as well as their blink detection rate. We found substantial agreement between signals: whereas, qualitatively, the NeuroSky MindWave presented higher levels of noise and a biphasic shape of blinks, the similarity metric indicated that signals from both recording devices were significantly correlated. While the NeuroSky MindWave was less reliable, both devices had a similar blink detection rate. Overall, the NeuroSky MindWave is noise-limited, but provides stable recordings even through long periods of time. Furthermore, its data would be of adequate quality compared to that of conventional wet electrode EEG devices, except for a potential calibration error and spectral differences at low frequencies.Spanish Department of Transportation, Madrid, Spain (Grant No. SPIP2014-1426 to L.L.D.S.)A.C. is funded by a Spanish Ministry of Economy and Competitiveness grant (PSI2016-80558-R to A.C.)S.R. is funded by an Andalusian Government Excellence Research grant (P11-TIC-7983)L.J.F. is funded by a Spanish Ministry of Economy and Competitiveness grant (PSI2014-53427-P) and a Fundación Séneca grant (19267/PI/14)L.L.D.S. is currently supported by the Ramón y Cajal fellowship program (RYC-2015-17483)C.D.-P. is currently supported by the CEIMAR program (CEIMAR2018-2)C.D.-P. and L.L.D.S. are supported by a Santander Bank—CEMIX UGR-MADOC grant (Project PINS 2018-15

Effects of vaccination against COVID-19 on the emotional health of older adults

Background: The COVID-19 pandemic significantly impacted the mental and emotional health of the elderly, especially those from low to middle-income countries. However, COVID-19 vaccination may reduce this influence. Therefore, we aimed to estimate the effect of vaccination against COVID-19 on the emotional health of older adults. Methods: We selected a national, random, and stratified sample of non-hospitalized adults aged 60 to 79 years from Peru who intended to receive or had already received the COVID-19 vaccine during recruitment. During June and July 2021, the assessed outcomes were the fear, anxiety, and worry about COVID-19, general anxiety, and depression at baseline and after a month. We estimated the adjusted odds ratios (aOR) and 95% confidence intervals (95% CI) for each altered emotional health outcomes in those who had one and two doses, compared with those who were not vaccinated using multilevel logistic regression with mixed effects. Results: We recruited 861 older adults with 20.8% of loss to follow-up. At baseline, 43.9% had received only one dose of the vaccine, and 49.1% had two doses. In the analysis during follow-up, those who had two doses had less fear (aOR: 0.19; CI 95%: 0.07 to 0.51) and anxiety to COVID-19 (aOR: 0.45; CI 95%: 0.22 to 0.89), compared to unvaccinated. We observed no effects in those with only one dose. Conclusions: Two doses of COVID-19 vaccination in older adults improves their perception of COVID-19 infection consequences. This information could be integrated into the vaccination campaign as an additional beneficial effect.Revisión por pare

Long-term effect of 2 intensive statin regimens on treatment and incidence of cardiovascular events in familial hypercholesterolemia : The SAFEHEART study

Funding: This study was supported by Fundación Hipercolesterolemia Familiar; Grant G03/181 Grant 08-2008 Centro Nacional de Investigaci?n Cardiovascular (CNIC).Background: Maximal doses of potent statins are the basement of treatment of familial hypercholesterolemia (FH). Little is known about the use of different statin regimens in FH. Objectives: The objectives of the study were to describe the treatment changes and low-density lipoprotein cholesterol (LDL-C) goal achievement with atorvastatin (ATV) and rosuvastatin (RV) in the SAFEHEART cohort, as well as to analyze the incidence of atherosclerotic cardiovascular events (ACVEs) and changes in the cardiovascular risk. Methods: SAFEHEART is a prospective follow-up nationwide cohort study in a molecularly defined FH population. The patients were contacted on a yearly basis to obtain relevant changes in life habits, medication, and ACVEs. Results: A total of 1939 patients were analyzed. Median follow-up was 6.6 years (5-10). The estimated 10-year risk according the SAFEHEART risk equation was 1.61 (0.67-3.39) and 1.22 (0.54-2.93) at enrollment for ATV and RV, respectively (P <.001). There were no significant differences at the follow-up: 1.29 (0.54-2.82) and 1.22 (0.54-2.76) in the ATV and RV groups, respectively (P =.51). Sixteen percent of patients in primary prevention with ATV and 18% with RV achieved an LDL-C <100 mg/dL and 4% in secondary prevention with ATV and 5% with RV achieved an LDL-C <70 mg/dL. The use of ezetimibe was marginally greater in the RV group. One hundred sixty ACVEs occurred during follow-up, being its incidence rate 1.1 events/100 patient-years in the ATV group and 1.2 in the RV group (P =.58). Conclusion: ATV and RV are 2 high-potency statins widely used in FH. Although the reduction in LDL-C levels was greater with RV than with ATV, the superiority of RV for reducing ACVEs was not demonstrated

Aerosol characterization at the Saharan AERONET site Tamanrasset

More than 2 years of columnar atmospheric aerosol measurements (2006–2009) at the Tamanrasset site (22.79° N, 5.53° E, 1377 m a.s.l.), in the heart of the Sahara, are analysed. Aerosol Robotic Network (AERONET) level 2.0 data were used. The KCICLO (K is the name of a constant and ciclo means cycle in Spanish) method was applied to a part of the level 1.5 data series to improve the quality of the results. The annual variability of aerosol optical depth (AOD) and Ångström exponent (AE) has been found to be strongly linked to the convective boundary layer (CBL) thermodynamic features. The dry-cool season (autumn and winter) is characterized by a shallow CBL and very low mean turbidity (AOD ~ 0.09 at 440 nm, AE ~ 0.62). The wet-hot season (spring and summer) is dominated by high turbidity of coarse dust particles (AE ~ 0.28, AOD ~ 0.39 at 440 nm) and a deep CBL. The aerosol-type characterization shows desert mineral dust as the prevailing aerosol. Both pure Saharan dust and very clear sky conditions are observed depending on the season. However, several case studies indicate an anthropogenic fine mode contribution from the industrial areas in Libya and Algeria. The concentration weighted trajectory (CWT) source apportionment method was used to identify potential sources of air masses arriving at Tamanrasset at several heights for each season. Microphysical and optical properties and precipitable water vapour were also investigated.The AERONET sun photometer at Tamanrasset has been calibrated within AERONET-EUROPE TNA supported by the PHOTONS and RIMA networks and partially financed by the European Community – Research Infrastructure Action under the Seventh Framework Programme (FP7/2007-2013) “Capacities” specific programme for Integrating Activities, ACTRIS grant agreement no. 262254. Financial support from the Spanish MINECO (projects CGL2011-23413, CGL2012-33576 and CGL2012-37505) is also gratefully acknowledged. J. M. Baldasano and S. Basart acknowledge the Supercomputación y eCiencia project (CSD2007-0050) from the Consolider-Ingenio 2010 and Severo Ochoa (SEV-2011-00067) programs of the Spanish Government

Longitudinal outcomes of obeticholic acid therapy in ursodiol-nonresponsive primary biliary cholangitis: Stratifying the impact of add-on fibrates in real-world practice

Background Suboptimal response to ursodeoxycholic acid occurs in 40% of primary biliary cholangitis (PBC) patients, affecting survival. Achieving a deep response (normalisation of alkaline phosphatase [ALP] and bilirubin ≤0.6 upper limit of normal) improves survival. Yet, the long-term effectiveness of second-line treatments remains uncertain. Aims To evaluate the long-term effectiveness of obeticholic acid (OCA) ± fibrates. Focusing on biochemical response (ALP ≤1.67 times the upper limit of normal, with a decrease of at least 15% from baseline and normal bilirubin levels), normalisation of ALP, deep response and biochemical remission (deep response plus aminotransferase normalisation). Methods We conducted a longitudinal, observational, multicentre study involving ursodeoxyccholic acid non-responsive PBC patients (Paris-II criteria) from Spain and Portugal who received OCA ± fibrates. Results Of 255 patients, median follow-up was 35.1 months (IQR: 20.2–53). The biochemical response in the whole cohort was 47.2%, 61.4% and 68.6% at 12, 24 and 36 months. GLOBE-PBC and 5-year UK-PBC scores improved (p < 0.001). Triple therapy (ursodeoxycholic acid plus OCA plus fibrates) had significantly higher response rates than dual therapy (p = 0.001), including ALP normalisation, deep response and biochemical remission (p < 0.001). In multivariate analysis, triple therapy remained independently associated with biochemical response (p = 0.024), alkaline phosphatase normalisation, deep response and biochemical remission (p < 0.001). Adverse effects occurred in 41.2% of cases, leading to 18.8% discontinuing OCA. Out of 55 patients with cirrhosis, 12 developed decompensation. All with baseline portal hypertension. Conclusion Triple therapy was superior in achieving therapeutic goals in UDCA-nonresponsive PBC. Decompensation was linked to pre-existing portal hypertension

The intrinsically disordered, epigenetic factor RYBP binds to the citrullinating enzyme PADI4 in cancer cells

14 p.-6 fig.-1 tab.RYBP (Ring1 and YY 1 binding protein) is a multifunctional, intrinsically disordered protein (IDP), best described as a transcriptional regulator. It exhibits a ubiquitin-binding functionality, binds to other transcription factors, and has a key role during embryonic development. RYBP, which folds upon binding to DNA, has a Zn-finger domain at its N-terminal region. By contrast, PADI4 is a well-folded protein and it is one the human isoforms of a family of enzymes implicated in the conversion of arginine to citrulline. As both proteins intervene in signaling pathways related to cancer development and are found in the same localizations within the cell, we hypothesized they may interact. We observed their association in the nucleus and cytosol in several cancer cell lines, by using immunofluorescence (IF) and proximity ligation assays (PLAs). Binding also occurred in vitro, as measured by isothermal titration calorimetry (ITC) and fluorescence, with a low micromolar affinity (~1 μM). AlphaFold2-multimer (AF2) results indicate that PADI4's catalytic domain interacts with the Arg53 of RYBP docking into its active site. As RYBP sensitizes cells to PARP (Poly (ADP-ribose) polymerase) inhibitors, we applied them in combination with an enzymatic inhibitor of PADI4 observing a change in cell proliferation, and the hampering of the interaction of both proteins. This study unveils for the first time the possible citrullination of an IDP, and suggests that this new interaction, whether it involves or not citrullination of RYBP, might have implications in cancer development and progression.This research was funded by Ministry of Science and Innovation MCIN/AEI/10.13039/501100011033/ and “ERDF A way of Making Europe” [PID2021-127296OB-I00 to AVC; and PDC2022-133952-I00 to EF]; by Instituto de Salud Carlos III co-funded by European Social Fund “Investing in your future” [CP19/00095 to CdJ] [PI22/00824 to MS and CdJ] [PI18/00394 to OA]; by Diputación General de Aragón [“Protein targets and Bioactive Compounds group” E45-20R to AVC, and “Digestive Pathology Group” B25-20R to OA], and by Consellería de Innovación, Universidades, Ciencia y Sociedad Digital (Generalitat Valenciana) [CAICO 2021/0135 to CdJ and JLN].Peer reviewe

Cardiovascular risk estimated after 13 years of follow-up in a low-incidence Mediterranean region with high-prevalence of cardiovascular risk factors

<p>Abstract</p> <p>Background</p> <p>Murcia (south-east Spain) shows increased cardiovascular (CV) morbimortality as compared to other Spanish regions. Our objective was to assess the CV risk associated with major risk factors (RF) among adult population of Murcia.</p> <p>Methods</p> <p>A cohort of 2314 subjects (18-70 years) with full biochemical and questionnaire data was followed-up for 13 years. Incident cases of ischemic heart disease and stroke were identified by record linkage, individual questionnaires and revision of medical records. Relative risks were obtained by multivariate Cox regression stratified by age and sex, and ischemic risk attributable to CVRF was calculated.</p> <p>Results</p> <p>After more than 26276 person-years of follow-up, 57 incident ischemic events (77% men) and 37 stroke cases (62% men) were identified. Independent risk factors of ischemic heart disease (IHD) and all CV events combined, with RR ranging from 1.6 to 2.6, were total serum cholesterol ≥ 240 mg/dl (HR = 2.6, 95%CI:1.3-5.1), blood pressure levels ≥ 140/90 mmHg (HR = 2.6, 95%CI:1.4-4.8), ever tobacco smoking (HR = 2.2; 95%CI:1.1-4.5), and diabetes (HR = 2.0; 95%CI: 1.0-3.8). No increased CV risk was detected for known participants under treatment who showed cholesterol and blood pressure values below the clinical risk threshold. Smoking was significantly associated with stroke. For all events combined, the major risk factors were hypercholesterolemia, hypertension and ever use of tobacco. Despite its high prevalence, obesity was not associated to CV risk. Most of the IHD cases were attributable to smoking (44%), hypertension (38%) and hypercholesterolemia (26%).</p> <p>Conclusions</p> <p>In the Region of Murcia, smoking accounted for the largest proportion of cardiovascular risk, whereas hypertension displaced hypercholesterolemia as the second leading cause of CV disease. Our study deepens in our understanding of the cardiovascular epidemiology in Spanish areas of Mediterranean Europe with relatively high cardiovascular morbimortality, that are poorly represented by the available risk equations.</p